SIGN UP

Sign up to get updates about our clinical trials and other exciting news close

logo-oncology-large

A FOCUS ON THOSE WHO HAVE FEW OPTIONS

People with rare, difficult-to-treat or advanced forms of cancer may have few treatment options. This can make the future feel uncertain.

Idera is committed to cancer research and investigating new medicines that have the potential to improve lives. Through this research, we also seek to contribute to the understanding of disease and the advancement of patient care, in collaboration with leading scientists and clinicians.

EXPLORE IDERA

logo-oncology-large

A FOCUS ON THOSE WHO HAVE FEW OPTIONS

People with rare, difficult-to-treat or advanced forms of cancer may have few treatment options. This can make the future feel uncertain.

Idera is committed to cancer research and investigating new medicines that have the potential to improve lives. Through this research, we also seek to contribute to the understanding of disease and the advancement of patient care, in collaboration with leading scientists and clinicians.

EXPLORE IDERA

Ongoing CANCER clinical research programs

TRIALS FOR
MELANOMA

Melanoma is a type of skin cancer that occurs in melanocytes, the cells that color the skin and make moles. It is the most serious type of skin cancer because it can spread or metastasize to other tissues and organs in the body. Metastatic melanoma often spreads to the tissue under the skin, lymph nodes, lungs, liver and brain. Recent advances in treatment have resulted in improved outcomes in some patients with metastatic melanoma. However, new treatments are still urgently needed to help more patients control their disease.

Click the link below to learn more about the Illuminate 204 trial for patients with advanced metastatic melanoma.

Melanoma

TRIALS FOR
MELANOMA